Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 6, 15 - 16 (2000)
doi:10.1038/71466
Multiple approaches to multiple sclerosis
Lawrence Steinman1
- Dept. of Neurology and Neurological Sciences, Beckman
Center for Molecular Medicine, B002, Stanford University, Stanford, California 94305, USA
e-mail: steinman@stanford.edu
Abstract
Multiple sclerosis results from the failure of several different regulatory mechanisms designed to protect against autoimmunity, suggesting multiple targets for therapeutic intervention. Three papers in this issue suggest that if tolerance to components of the nervous system is not maintained in the thymus and autoimmunity ensues, the extent of brain damage can be checked by blockade of glutamate receptors on neurons and oligodendrocytes (56–70).
To read this story in full you will need to login or make a payment (see right).
